Navigation Links
John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
Date:12/7/2010

HACKENSACK, N.J. (December 7, 2010 at 7:30am) The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings presented at the annual meeting of the American Society of Hematology (ASH) taking place December 4-7, 2010 in Orlando, Florida. The ASH meeting is the world's leading scientific gathering of hematologists and hematology researchers.

Research highlights from the 40 abstracts from the John Theurer Cancer Center include a comparison of treatment with stem cell transplantation versus continued combination drug therapy for early-stage myeloma; tests of a newly approved drug for patients unresponsive to a second-line therapy for an aggressive lymphoma; a phase 2 study of a promising acute myelogenous leukemia drug; a trial of a new proteasome inhibitor for myeloma patients whose disease had not responded to other therapies; a study comparing low and high-dose therapies in newly diagnosed myeloma; and a study of a new approach to increase the effectiveness of stem cell transplantation.

"This year, we showcased 12 oral sessions and 28 poster presentations at ASH, including multicenter, international trials in collaboration with leading cancer institutions, such as the National Cancer Institute, MD Anderson, Dana-Farber, Mayo Clinic, Cleveland Clinic and Memorial Sloan-Kettering," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center. "We are proud that our research improves outcomes for our patients and helps set new benchmarks for the cancer treatment community."

The studies presented by the John Theurer Cancer Center include research advancements in lymphoma, multiple myeloma, stem cell transplantation, and leukemia. Oral and poster presentation highlights being presented at ASH include:

A Randomized Clinical Trial of Lenalidomide Plus Dexamethasone Followed by Autolog
'/>"/>

Contact: Amy Leahing
amy.leahing@gmail.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
2. John Theurer Cancer Center to present innovative research at 2 surgical meetings
3. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
4. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
7. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
8. John Theurer Cancer Center offers breakthrough radiation measurement technology
9. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
10. Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent
11. Daily Aspirin Linked to Steep Drop in Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... leader, Professor John Mathews from the University of Melbourne ... weighed against the undoubted benefits from CT scans in ... reported in the British Medical Journal today ... Oxford University, and the International Agency for Research on ... "CT scans were very useful in providing detailed three ...
(Date:5/22/2013)... percent of patients being treated for COPD at ... disease, researchers found after evaluating the patients with ... pulmonary disease. , "While there have been many ... not been a U.S.-based study that has quantified ... MSc, a second-year medical resident at Saint ...
(Date:5/22/2013)... The PreDiabetes Center of King ... Greater Philadelphia Tour de Cure, a premier cycling event that ... about stopping the spread of diabetes , a chronic ... The Tour de Cure will take place Saturday, June 1 ... Ambler, 30 minutes outside of Philadelphia, between the hours of ...
(Date:5/22/2013)... Detroit, Michigan (PRWEB) May 22, 2013 ... free service filters through local businesses and connects consumers ... seconds. Detroit’s residents have less time to handle personal ... their longer commutes to and from work. So, they ... searching for the right local available professional. , Now, ...
(Date:5/22/2013)... 22, 2013 CoCENTRIX, a leading ... Health and Human Services and community providers, announced ... (ADMH) selected the CoCENTRIX Coordinated Care Platform ... the Health Records and coordinate care within and ... , CoCENTRIX is transitioning the hospitals' official records ...
Breaking Medicine News(10 mins):Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3
... HealthDay Reporter , TUESDAY, May 15 (HealthDay News) -- ... works well in adolescents, new research indicates. Although ... "it is nice to have this officially shown in ... director of neurology at Maimonides Medical Center in New ...
... acid taken up to three times their recommended daily ... higher levels as some supplement manufacturers suggest, these three supplements ... a host of cancers. , "It,s not that these nutrients ... we need them in a certain balance," says Tim Byers, ...
... suggests that specific populations of tumor cells have different roles ... themselves and grow. In their report in the May ... tumor-propagating cell required for the growth of a pediatric muscle ... more-differentiated tumor cell must first travel to sites of new ...
... June,s Journal of Thoracic Oncology says molecular biomarkers ... an additional predictive technique for lung cancer screening. , ... of the positive CT screening results were false positive, scientists ... This research focused on a way to determine if the ...
... (SACRAMENTO, Calif.) A vaccine that targets cancer cells in ... breast cancer, significantly increased survival when tested in mice, a ... findings will be published today in the journal Clinical ... and the hormonal drug letrozole were more effective when given ...
... 15 (HealthDay News) -- Patient education and medication compliance contributed ... with life-threatening asthma admitted to the intensive care unit at ... review of 30 years of hospital data focused on patients ... They found that there were 227 patients admitted to the ...
Cached Medicine News:Health News:Two-Drug Combo Helps Teens With Migraines 2Health News:All cancer cells are not created equal 2Health News:All cancer cells are not created equal 3Health News:Cancer vaccine combination therapy shows survival benefit in breast cancer 2Health News:Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study 2
(Date:5/22/2013)... 2013  Grifols, a global healthcare company based in ... a study demonstrating that a higher dose of PROLASTIN ... of the alpha 1 protein in patients with ... considered within the normal range for healthy individuals. AAT ... levels of the alpha 1 proteinase inhibitor (A1PI) ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... While many parents may think that allowing ... home under adult supervision keeps kids safe and leads ... there are serious negative consequences for both parents and ... The Treatment Research Institute (TRI) today announced the ... and caregivers to help inform them about one of ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7
... June 28, 2011 The Mirixa Corporation and ... are pleased to announce that MirixaPro(SM), a Web-based ... patient care service delivery, will be deployed in ... agreement enabling CACDS to use a scalable, localized ...
... 2011 ,   The ... range of,new clinical data. The "Late-Breaking Clinical Trials" were ... SHPT study,(Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet,With ... June the,principal investigator of this study, Prof. Markus Ketteler,(Coburg, ...
Cached Medicine Technology:Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 2Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 3Update on IMPACT Study Results 2
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
... and ristocetin cofactor testing, couples a ... Windows-based software for unsurpassed testing flexibility. ... can be run on one Remote ... configure your analyzers to suite your ...
... Model 700 Whole Blood/Optical Lumi-Aggregometer available in ... new Aggregometer measures platelet function on patient ... or optical density in plasma with simultaneously ... The Model 700 Aggregometer also has the ...
Medicine Products: